aTyr Pharma, Inc. (ATYR)
0.2783
-0.01
(-1.80%)
USD |
NASDAQ |
Oct 07, 16:00
0.2749
0.00 (0.00%)
Pre-Market: 08:08
aTyr Pharma Price to Book Value : 0.5595 for Oct. 7, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 07, 2026 | 0.5595 |
| October 06, 2026 | 0.5698 |
| October 05, 2026 | 0.583 |
| October 02, 2026 | 0.5774 |
| October 01, 2026 | 0.5913 |
| September 30, 2026 | 0.6092 |
| September 29, 2026 | 0.6186 |
| September 28, 2026 | 0.5985 |
| September 25, 2026 | 0.6132 |
| September 24, 2026 | 0.6787 |
| September 23, 2026 | 0.7543 |
| September 22, 2026 | 0.7165 |
| September 21, 2026 | 0.7495 |
| September 18, 2026 | 0.7298 |
| September 17, 2026 | 0.757 |
| September 16, 2026 | 0.7722 |
| September 15, 2026 | 0.7825 |
| September 14, 2026 | 0.7813 |
| September 11, 2026 | 0.8641 |
| September 10, 2026 | 0.8683 |
| September 09, 2026 | 0.9156 |
| September 08, 2026 | 0.9666 |
| September 04, 2026 | 0.9998 |
| September 03, 2026 | 1.012 |
| September 02, 2026 | 0.9912 |
| Date | Value |
|---|---|
| September 01, 2026 | 0.958 |
| August 31, 2026 | 1.069 |
| August 28, 2026 | 1.086 |
| August 27, 2026 | 1.115 |
| August 26, 2026 | 1.108 |
| August 25, 2026 | 1.146 |
| August 24, 2026 | 1.066 |
| August 21, 2026 | 1.008 |
| August 20, 2026 | 1.011 |
| August 19, 2026 | 1.071 |
| August 18, 2026 | 1.014 |
| August 17, 2026 | 1.043 |
| August 14, 2026 | 1.124 |
| August 13, 2026 | 1.112 |
| August 12, 2026 | 1.086 |
| August 11, 2026 | 1.074 |
| August 10, 2026 | 1.063 |
| August 07, 2026 | 1.028 |
| August 06, 2026 | 1.009 |
| August 05, 2026 | 1.064 |
| August 04, 2026 | 1.064 |
| August 03, 2026 | 0.9892 |
| July 31, 2026 | 0.9765 |
| July 30, 2026 | 0.965 |
| July 29, 2026 | 0.9711 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Alnylam Pharmaceuticals, Inc. | 22.16 |
| ACADIA Pharmaceuticals, Inc. | 2.589 |
| Savara, Inc. | 6.977 |
| Vericel Corp. | 5.634 |
| Biogen, Inc. | 1.741 |
Price to Book Value Related Metrics
| PS Ratio | 143.28 |
| Price | 0.2783 |
| Earnings Yield | -223.8% |
| Market Cap | 27.30M |